Sun Life Financial Inc. has announced the retirement of Chief Executive Officer Dean Connor, confirming that the long-term leader will hand the reins over to existing Chief Financial Officer Kevin Strain in August of next year.
In addition to taking the role of CEO, the 54-year-old businessman will also assume...
With online spending on Black Friday rising by 21.6% to $9 billion this year, Cyber Monday has been projected to be the biggest online shopping day to date. With sales estimates being projected to be anywhere between $10.8 billion and $12.7 billion, the NYSE has seen some major movements...
With Moderna’s coronavirus vaccine candidate achieving an effectiveness rate of over 94% during the latest clinical trials, the biotech company completed a deal with the European Commission for the supply of at least 80 million doses of its vaccine, with the volume potentially amounting to 160 million depending on...
While U.S. crude supplies have experienced a steady decline in recent times, oil has managed to retain its eight-month market highs. While an Energy Information Administration report showed a 754,000 decline in crude barrels last week, oil futures rose by 1.8% on the New York Stock Exchange.
These enduring highs...
After a 17% surge on Tuesday that resulted in a two-month high, hydrogen vehicle manufacturer Nikola suffered a 15% decrease in stock prices as markets came to a close. The Phoenix-based firm enjoyed a significant rise over the past few weeks in line with the electric vehicle market.
Nikola’s late...
With the likes of Pfizer and Moderna leading in the race to a coronavirus vaccine, AstraZeneca shares have dropped by 3% following the company’s announcement that its vaccine candidate has proven to be 70% effective. This figure is significantly lower than that of Pfizer and Moderna.
In its phase 3...
With Moderna expected to soon file its COVID-19 vaccine for emergency use in the United States, the biotech company decided to sell $1.74 million worth of new shares. The Cambridge, Massachusetts-based company will be the second firm to file for emergency use of its vaccine, the first being Pfizer...
American biotech company Moderna (MRNA) released a preview of its latest COVID-19 testing data on Monday, revealing that its vaccine has been proven to be 94.5% effective in the latest round of testing. In addition, this vaccine has been shown to exhibit an even longer shelf life in the...
The Dow Jones, S&P 500, and Nasdaq indexes all enjoyed reaching record highs in the past week, with market activities being heavily influenced by news regarding the race to develop a COVID-19 vaccine.
Pfizer (PFE) and BioNTech (BNTX), who are at the forefront of the development of the first effective...